Non-viral-mediated gene therapy approaches for bone repair

Area of Science:

• Biomaterials Science
• Gene Therapy
• Tissue Engineering

Background:

• Current bone repair strategies seek alternatives to autografts and allografts.
• Gene therapy, involving DNA delivery to wound beds, is explored for bone regeneration.
• Enhancing non-viral gene delivery, uptake, and expression is crucial for effective bone repair.

Purpose of the Study:

• To investigate methods for improving non-viral gene therapy for bone regeneration.
• To evaluate DNA-polymer complexes for enhanced gene uptake and expression.
• To assess the role of gene-activated matrices (GAMs) in non-viral gene delivery.

Main Methods:

• In vitro evaluation of DNA-polymer complexes (lipophilic reagent, liposomes, poly-ethyl-oxazoline, poly-ethyleneimine) for cell transfection.
• Comparison of direct DNA-polymer complex application versus release from resorbable GAMs.
• Assessment of green fluorescent protein expression in baby hamster kidney (BHK) cells.

Main Results:

• Gene-activated matrix (GAM) technology improved in vitro transfection efficiencies of liposome and poly-ethyleneimine (PEI) complexes.
• Lipophilic reagent FuGene 6 showed high initial uptake and expression.
• DNA-liposome and PEI GAM complexes demonstrated sustained DNA release, uptake, and expression over 7 days.

Conclusions:

• Gene-activated matrix (GAM) technology enhances functional stability and release duration of DNA-polymer complexes.
• GAMs show potential for improving non-viral gene therapy in bone regeneration.
• Further research aims to develop localized treatments for enhanced plasmid DNA uptake and expression.